Numerous articles have detailed the Supreme Court’s groundbreaking decision in Bristol-Myers Squibb Co. v. Superior Ct., 137 S. Ct. 1773 (2017) (BMS). This article addresses the mechanics and practical considerations when deciding whether to use BMS to break up a mass action.

To read the article, click here.